Adaptimmune Therapeutics PLC financial data

Symbol
ADAP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom
State of incorporation
United Kingdom
Fiscal year end
December 31
Former names
Adaptimmune Ltd (to 3/17/2015)
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % +0.67%
Debt-to-equity 438 % +69.8%
Return On Assets -24.8 % +34.1%
Operating Margin -38.6 % +83.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.54B shares +4.22%
Common Stock, Shares, Outstanding 1.54B shares +12.7%
Entity Public Float 231M USD +20.7%
Common Stock, Value, Issued 2.09M USD +11.8%
Weighted Average Number of Shares Outstanding, Basic 1.51B shares +25.5%
Weighted Average Number of Shares Outstanding, Diluted 1.51B shares +25.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40.9M USD +459%
Revenue from Contract with Customer, Excluding Assessed Tax 178M USD +195%
Research and Development Expense 149M USD +17.8%
General and Administrative Expense 71.9M USD -0.89%
Costs and Expenses 247M USD +23.4%
Operating Income (Loss) -68.8M USD +50.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -67.2M USD +40.3%
Income Tax Expense (Benefit) 3.58M USD +168%
Net Income (Loss) Attributable to Parent -70.8M USD +37.8%
Earnings Per Share, Basic -0.05 USD/shares +44.4%
Earnings Per Share, Diluted -0.05 USD/shares +44.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.1M USD -36.7%
Accounts Receivable, after Allowance for Credit Loss, Current 1.45M USD +77.1%
Inventory, Net 7.32M USD
Other Assets, Current 3.17M USD +31.4%
Assets, Current 188M USD -9.34%
Property, Plant and Equipment, Net 31.3M USD -38.5%
Operating Lease, Right-of-Use Asset 19.9M USD -4.11%
Intangible Assets, Net (Excluding Goodwill) 3.88M USD +1076%
Other Assets, Noncurrent 629K USD
Assets 246M USD -13%
Accounts Payable, Current 8.69M USD +6.94%
Employee-related Liabilities, Current 13.5M USD +2.29%
Accrued Liabilities, Current 32.9M USD +8.63%
Contract with Customer, Liability, Current 12.3M USD -57.6%
Liabilities, Current 64.5M USD -11.3%
Contract with Customer, Liability, Noncurrent 147M USD +23.6%
Operating Lease, Liability, Noncurrent 19.3M USD -2.96%
Other Liabilities, Noncurrent 4.27M USD +204%
Liabilities 234M USD -3.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.9M USD +49.3%
Retained Earnings (Accumulated Deficit) -1.09B USD -6.92%
Stockholders' Equity Attributable to Parent 11.8M USD -70%
Liabilities and Equity 246M USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32M USD +14.3%
Net Cash Provided by (Used in) Financing Activities 29.2M USD +14816%
Net Cash Provided by (Used in) Investing Activities -358K USD -101%
Common Stock, Shares Authorized 2.04B shares +19.8%
Common Stock, Shares, Issued 1.54B shares +12.7%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49M USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.2M USD -36.6%
Deferred Tax Assets, Valuation Allowance 309M USD +4.94%
Deferred Tax Assets, Gross 313M USD +3.67%
Operating Lease, Liability 24M USD -5.01%
Depreciation 2.77M USD +67%
Payments to Acquire Property, Plant, and Equipment 102K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69M USD +40.9%
Lessee, Operating Lease, Liability, to be Paid 31.7M USD +4.49%
Property, Plant and Equipment, Gross 83.2M USD -14.2%
Operating Lease, Liability, Current 4.71M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.56M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.81M USD -4.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +24.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.77M USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.19M USD -4.31%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.25M USD -23.9%
Additional Paid in Capital 1.11B USD +3.86%
Deferred Tax Assets, Net of Valuation Allowance 3.61M USD -49.1%
Share-based Payment Arrangement, Expense 12.1M USD +2.36%